Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1941 2
1943 1
1944 2
1946 11
1947 11
1948 20
1949 17
1950 28
1951 39
1952 36
1953 46
1954 37
1955 55
1956 32
1957 43
1958 34
1959 43
1960 34
1961 35
1962 25
1963 69
1964 82
1965 63
1966 88
1967 97
1968 119
1969 103
1970 114
1971 113
1972 123
1973 138
1974 133
1975 154
1976 148
1977 188
1978 156
1979 184
1980 200
1981 205
1982 221
1983 263
1984 254
1985 329
1986 268
1987 303
1988 259
1989 314
1990 307
1991 334
1992 332
1993 354
1994 405
1995 393
1996 426
1997 427
1998 448
1999 471
2000 501
2001 567
2002 566
2003 618
2004 708
2005 811
2006 889
2007 900
2008 988
2009 972
2010 1136
2011 1166
2012 1352
2013 1490
2014 1573
2015 1641
2016 1815
2017 1745
2018 2057
2019 2143
2020 2381
2021 2740
2022 2752
2023 2792
2024 3262
2025 3913
2026 1662

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47,031 results

Results by year

Filters applied: . Clear all
Page 1
Healon.
Miller D. Miller D. Ann Ophthalmol. 1981 Jul;13(7):781-2. Ann Ophthalmol. 1981. PMID: 7294614 No abstract available.
The use of Healon in intraocular lens implantation.
Miller D, Stegmann R. Miller D, et al. Int Ophthalmol Clin. 1982 Summer;22(2):177-87. doi: 10.1097/00004397-198202220-00011. Int Ophthalmol Clin. 1982. PMID: 7045006 Review. No abstract available.
Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate.
Becker LC, Bergfeld WF, Belsito DV, Klaassen CD, Marks JG Jr, Shank RC, Slaga TJ, Snyder PW; Cosmetic Ingredient Review Expert Panel; Andersen FA. Becker LC, et al. Int J Toxicol. 2009 Jul-Aug;28(4 Suppl):5-67. doi: 10.1177/1091581809337738. Int J Toxicol. 2009. PMID: 19636067
Hyaluronic acid, sodium hyaluronate, and potassium hyaluronate function in cosmetics as skin conditioning agents at concentrations up to 2%. ...Hyaluronic acid was not genotoxic. Hyaluronic acid likely does not play a causal
Hyaluronic acid, sodium hyaluronate, and potassium hyaluronate function in cosmetics as skin conditioning agents
Blue Healon.
Drews RC, Gabrawy L. Drews RC, et al. J Cataract Refract Surg. 1989 Jan;15(1):100-4. doi: 10.1016/s0886-3350(89)80150-6. J Cataract Refract Surg. 1989. PMID: 2921725 Clinical Trial.
A random prospective study comparing clear sodium hyaluronate (Healon) and blue Healon was done in 50 patients who had routine extracapsular cataract surgery with lens implantation. Blue Healon was more visible and easier to remove. For this reason the …
A random prospective study comparing clear sodium hyaluronate (Healon) and blue Healon was done in 50 patients who had …
[Comparison of Healon, Healon GV, and Healon 5 in viscotrabeculectomy].
Löw M, Bühler C, Mester U. Löw M, et al. Ophthalmologe. 2003 Jul;100(7):539-44. doi: 10.1007/s00347-002-0769-8. Epub 2003 Jun 25. Ophthalmologe. 2003. PMID: 12920554 German.
METHODS: One hundred seventy-one eyes of 149 consecutive patients underwent TE or PT. In all cases, Healon, Healon GV, or Healon 5 was instilled in the anterior chamber at the beginning of surgery and left there at the end. ...Postoperative IOP spikes did not …
METHODS: One hundred seventy-one eyes of 149 consecutive patients underwent TE or PT. In all cases, Healon, Healon GV, or H
Using Healon to identify the lumen of the sac in dacryocystorhinostomy.
Shiwa T, Tazawa Y. Shiwa T, et al. Ophthalmic Surg. 1991 Sep;22(9):546-7. Ophthalmic Surg. 1991. PMID: 1945281
Sodium hyaluronate (Healon) injected into the lacrimal sac, facilitates a full-thickness cut of the lacrimal sac in cases in which it is difficult to identify the lumen of the sac. The sodium hyaluronate does not stain tissues, is effective for hemostasis, an …
Sodium hyaluronate (Healon) injected into the lacrimal sac, facilitates a full-thickness cut of the lacrimal sac in cases in w …
Comparison of the effect of Healon, Healon GV, Healon 5, Viscoat, and Ocucoat on platelet aggregation under in vitro conditions.
Aras C, Baslar Z, Unal M, Horoz H. Aras C, et al. Eur J Ophthalmol. 2006 Mar-Apr;16(2):306-10. doi: 10.1177/112067210601600218. Eur J Ophthalmol. 2006. PMID: 16703551
PURPOSE: To study the effect of Healon, Healon GV, Healon 5, Viscoat, and OcuCoat on platelet aggregation under in vitro conditions. ...The mean percentage of maximal aggregation was 67 +/- 3% for Healon, 77.66 +/- 4.04% for Healon GV, 77 +/- 4% …
PURPOSE: To study the effect of Healon, Healon GV, Healon 5, Viscoat, and OcuCoat on platelet aggregation under in vitr …
Healon5 viscoadaptive formulation: Comparison to Healon and Healon GV.
Dick HB, Krummenauer F, Augustin AJ, Pakula T, Pfeiffer N. Dick HB, et al. J Cataract Refract Surg. 2001 Feb;27(2):320-6. doi: 10.1016/s0886-3350(00)00482-x. J Cataract Refract Surg. 2001. PMID: 11226801
METHODS: An independent comparative study of 3 OVDs of sodium hyaluronate (Healon(R), Healon GV(R), and Healon(R)5) was performed using the Advanced Rheometric Expansion System to analyze rheologic behavior (eg, dynamic frequency dependence of the comp …
METHODS: An independent comparative study of 3 OVDs of sodium hyaluronate (Healon(R), Healon GV(R), and Healon(R …
Effect of Healon and Viscoat on outflow facility in human cadaver eyes.
Lane D, Motolko M, Yan DB, Ethier CR. Lane D, et al. J Cataract Refract Surg. 2000 Feb;26(2):277-81. doi: 10.1016/s0886-3350(99)00357-0. J Cataract Refract Surg. 2000. PMID: 10683798
PURPOSE: To compare the acute effects of Healon (sodium hyaluronate) and Viscoat (sodium chondroitin sulfate-sodium hyaluronate) on outflow facility in human cadaver eyes and determine which viscoelastic agent is least likely to cause an intraocular pressure …
PURPOSE: To compare the acute effects of Healon (sodium hyaluronate) and Viscoat (sodium chondroitin sulfate-sodium hyaluro
47,031 results
You have reached the last available page of results. Please see the User Guide for more information.